Exercise Therapy and Jaw-Mobilizing Device for Trismus in Head and Neck Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

October 31, 2024

Conditions
Head and Neck CancersTrismusRadiotherapy Side Effects
Interventions
BEHAVIORAL

combination of exercise therapy and a jaw-mobilizing device

Participants in the experimental group will receive a combination of exercise therapy and a jaw-mobilizing device. The intervention includes structured exercise therapy sessions and the use of the jaw-mobilizing device for 12 weeks, beginning one week prior to radiotherapy. Follow-ups will occur at weeks 16, 24, and 36 to assess outcomes.

BEHAVIORAL

exercise therapy only

Participants in the control group will receive exercise therapy only. This intervention involves the same structured exercise therapy sessions as the experimental group for 12 weeks, beginning one week prior to radiotherapy. Follow-ups will occur at weeks 16, 24, and 36 to assess outcomes.

Trial Locations (1)

Unknown

tri-Service Gereral Hospital, Taipei

All Listed Sponsors
lead

Taipei Medical University

OTHER

NCT06719388 - Exercise Therapy and Jaw-Mobilizing Device for Trismus in Head and Neck Cancer Patients | Biotech Hunter | Biotech Hunter